耳鼻咽喉科指南

订阅

MedSci主页 / 所有栏目 / 耳鼻咽喉科指南

英国鼻科学会鼻出血多学科治疗指南及共识解读

2019-11-01 临床耳鼻咽喉头颈外科杂志.2019.33(17):1022-1026.

鼻衄住院管理

鼻出血是耳鼻咽喉科常见急症之一,发病率较高,我国于2015年制定了鼻出血治疗指南,已成为临床医生在鼻出血诊疗过程中的重要依据。英国于2016年也制定了鼻出血治疗指南,2017年就指南内容进行了深入的讨论和探究并达成共识。我国和英国关于鼻出血的治疗指南均从初步评估、烧灼术、鼻腔填塞、血液系统因素、手术治疗及介入治疗5个方面对鼻出血的治疗进行指导。本文对上述2个重要指南及共识进行解读,以期为我国鼻出血

中文标题：

英国鼻科学会鼻出血多学科治疗指南及共识解读

发布机构：

发布日期：

2019-11-01

简要介绍：

鼻出血是耳鼻咽喉科常见急症之一,发病率较高,我国于2015年制定了鼻出血治疗指南,已成为临床医生在鼻出血诊疗过程中的重要依据。英国于2016年也制定了鼻出血治疗指南,2017年就指南内容进行了深入的讨论和探究并达成共识。我国和英国关于鼻出血的治疗指南均从初步评估、烧灼术、鼻腔填塞、血液系统因素、手术治疗及介入治疗5个方面对鼻出血的治疗进行指导。本文对上述2个重要指南及共识进行解读,以期为我国鼻出血治疗指南的制定提供帮助。

作者： 吉林大学中日联谊医院耳鼻咽喉头颈外科 刘懿霆 沙骥超 朱冬冬 谢竞 孟粹达 

拓展指南：与鼻出血相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=英国鼻科学会鼻出血多学科治疗指南及共识解读)] GetToolGuiderByIdResponse(projectId=1, id=b65991c0018250cd, title=英国鼻科学会鼻出血多学科治疗指南及共识解读, enTitle=, guiderFrom=临床耳鼻咽喉头颈外科杂志.2019.33(17):1022-1026., authorId=null, author=, summary=鼻出血是耳鼻咽喉科常见急症之一,发病率较高,我国于2015年制定了鼻出血治疗指南,已成为临床医生在鼻出血诊疗过程中的重要依据。英国于2016年也制定了鼻出血治疗指南,2017年就指南内容进行了深入的讨论和探究并达成共识。我国和英国关于鼻出血的治疗指南均从初步评估、烧灼术、鼻腔填塞、血液系统因素、手术治疗及介入治疗5个方面对鼻出血的治疗进行指导。本文对上述2个重要指南及共识进行解读,以期为我国鼻出血, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Nov 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>鼻出血是耳鼻咽喉科常见急症之一,发病率较高,我国于2015年制定了鼻出血治疗指南,已成为临床医生在鼻出血诊疗过程中的重要依据。英国于2016年也制定了鼻出血治疗指南,2017年就指南内容进行了深入的讨论和探究并达成共识。我国和英国关于鼻出血的治疗指南均从初步评估、烧灼术、鼻腔填塞、血液系统因素、手术治疗及介入治疗5个方面对鼻出血的治疗进行指导。本文对上述2个重要指南及共识进行解读,以期为我国鼻出血治疗指南的制定提供帮助。 </P> <P>作者： 吉林大学中日联谊医院耳鼻咽喉头颈外科 刘懿霆 沙骥超 朱冬冬 谢竞 孟粹达 </P>拓展指南：<strong>与<font color=red>鼻出血</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=699261c0015381b0" title="2017 BRS多学科共识建议：鼻出血的住院管理" target=_blank>2017 BRS多学科共识建议：鼻出血的住院管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=7b8ae1c00132808f" title="2016 SFORL指南：抗栓治疗导致的鼻出血凝血障碍的管理" target=_blank>2016 SFORL指南：抗栓治疗导致的鼻出血凝血障碍的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6f42f1c00132138f" title="2016 SFORL指南：成人鼻出血的一线治疗" target=_blank>2016 SFORL指南：成人鼻出血的一线治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d9f701c00131aea9" title="2016 SFORL指南：成人鼻出血的二线治疗" target=_blank>2016 SFORL指南：成人鼻出血的二线治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=085c01c001308ae1" title="2016 SFORL指南：鼻出血和高血压" target=_blank>2016 SFORL指南：鼻出血和高血压</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E9%BC%BB%E5%87%BA%E8%A1%80" target=_blank>有关鼻出血更多指南</a></ul>, tagList=[TagDto(tagId=96576, tagName=鼻衄), TagDto(tagId=67376, tagName=住院管理)], categoryList=[CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3883, appHits=212, showAppHits=0, pcHits=2298, showPcHits=2259, likes=60, shares=4, comments=7, approvalStatus=1, publishedTime=Sat Nov 09 23:23:01 CST 2019, publishedTimeString=2019-11-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 09 23:23:01 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:15:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=英国鼻科学会鼻出血多学科治疗指南及共识解读)])
英国鼻科学会鼻出血多学科治疗指南及共识解读
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1230567, encodeId=9c89123056e21, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f255431095, createdName=ms2000000170745693, createdTime=Mon Jul 04 22:15:11 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188847, encodeId=de7d118884e75, content=需要!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:57:57 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007856, encodeId=9137100e8566e, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab5512795, createdName=ms7000002136610823, createdTime=Sat Aug 14 15:33:24 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007131, encodeId=1a98100e13122, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/f57c872099474e4296cf2003dc83f244/2c7b6201c126492e826e645953c5f35d.jpg, createdBy=a84f5207031, createdName=misty, createdTime=Wed Aug 11 23:19:41 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890378, encodeId=493b8903e8db, content=😄😄😄, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86135423025, createdName=ms8000000526922998, createdTime=Tue Oct 06 16:10:41 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2022-07-04 ms2000000170745693

    需要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1230567, encodeId=9c89123056e21, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f255431095, createdName=ms2000000170745693, createdTime=Mon Jul 04 22:15:11 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188847, encodeId=de7d118884e75, content=需要!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:57:57 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007856, encodeId=9137100e8566e, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab5512795, createdName=ms7000002136610823, createdTime=Sat Aug 14 15:33:24 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007131, encodeId=1a98100e13122, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/f57c872099474e4296cf2003dc83f244/2c7b6201c126492e826e645953c5f35d.jpg, createdBy=a84f5207031, createdName=misty, createdTime=Wed Aug 11 23:19:41 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890378, encodeId=493b8903e8db, content=😄😄😄, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86135423025, createdName=ms8000000526922998, createdTime=Tue Oct 06 16:10:41 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2022-01-28 1dd94fafm20(暂无匿称)

    需要!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1230567, encodeId=9c89123056e21, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f255431095, createdName=ms2000000170745693, createdTime=Mon Jul 04 22:15:11 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188847, encodeId=de7d118884e75, content=需要!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:57:57 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007856, encodeId=9137100e8566e, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab5512795, createdName=ms7000002136610823, createdTime=Sat Aug 14 15:33:24 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007131, encodeId=1a98100e13122, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/f57c872099474e4296cf2003dc83f244/2c7b6201c126492e826e645953c5f35d.jpg, createdBy=a84f5207031, createdName=misty, createdTime=Wed Aug 11 23:19:41 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890378, encodeId=493b8903e8db, content=😄😄😄, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86135423025, createdName=ms8000000526922998, createdTime=Tue Oct 06 16:10:41 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2021-08-14 ms7000002136610823

    需要

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1230567, encodeId=9c89123056e21, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f255431095, createdName=ms2000000170745693, createdTime=Mon Jul 04 22:15:11 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188847, encodeId=de7d118884e75, content=需要!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:57:57 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007856, encodeId=9137100e8566e, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab5512795, createdName=ms7000002136610823, createdTime=Sat Aug 14 15:33:24 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007131, encodeId=1a98100e13122, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/f57c872099474e4296cf2003dc83f244/2c7b6201c126492e826e645953c5f35d.jpg, createdBy=a84f5207031, createdName=misty, createdTime=Wed Aug 11 23:19:41 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890378, encodeId=493b8903e8db, content=😄😄😄, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86135423025, createdName=ms8000000526922998, createdTime=Tue Oct 06 16:10:41 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2021-08-11 misty

    需要

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1230567, encodeId=9c89123056e21, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f255431095, createdName=ms2000000170745693, createdTime=Mon Jul 04 22:15:11 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188847, encodeId=de7d118884e75, content=需要!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76d61636229, createdName=1dd94fafm20(暂无匿称), createdTime=Fri Jan 28 15:57:57 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007856, encodeId=9137100e8566e, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab5512795, createdName=ms7000002136610823, createdTime=Sat Aug 14 15:33:24 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007131, encodeId=1a98100e13122, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/f57c872099474e4296cf2003dc83f244/2c7b6201c126492e826e645953c5f35d.jpg, createdBy=a84f5207031, createdName=misty, createdTime=Wed Aug 11 23:19:41 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890378, encodeId=493b8903e8db, content=😄😄😄, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86135423025, createdName=ms8000000526922998, createdTime=Tue Oct 06 16:10:41 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-06 ms8000000526922998

    😄😄😄

    0